IPO registrations (S-1, F-1) · Registrants
LIFECORE BIOMEDICAL, INC. \DE\
- SEC CIK
- 1005286 · filings on EDGAR ↗
- Former names
- LANDEC CORP \CA\ (1996–2022)
- Registration
- Form S-1, first filed 1996-07-03, last 2024-10-10; 3 initial registrations, 1 amendment
- Outcome
- Declared effective 2015-11-02
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 3515 LYMAN BOULEVARD, Chaska, MN 55318
- EIN
- 94-3025618
- Ticker
- LFCR (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- LIFECORE BIOMEDICAL, INC. \DE\ on the corporate pages
Offering terms
- Shares offered
- 866,569
- Listing
- Nasdaq under the symbol LFCR
- Lead underwriters
- Chaska, Minnesota (55,318 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: LIFECORE BIOMEDICAL INC. EXACT (EIN (EXACT))
- Form D issuer: LANDEC CORP \CA\ EXACT (CIK (EXACT))
- SEC filer: LANDEC CORP \CA\ EXACT (CIK (EXACT))
- Person page: Craig A Barbarosh Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1996-07-03 | S-1 | S-1 (registration) | LANDEC CORP \CA\ | 0000950109-96-004250 ↗ |
| 2015-11-02 | EFFECT | EFFECT (declared effective) | LANDEC CORP \CA\ | 9999999995-15-002934 ↗ |
| 2023-04-06 | S-1 | S-1 (registration) | LIFECORE BIOMEDICAL, INC. \DE\ | 0001628280-23-011053 ↗ |
| 2023-06-06 | S-1/A | S-1/A (amendment) | LIFECORE BIOMEDICAL, INC. \DE\ | 0001628280-23-021123 ↗ |
| 2023-06-09 | EFFECT | EFFECT (declared effective) | LIFECORE BIOMEDICAL, INC. \DE\ | 9999999995-23-001705 ↗ |
| 2024-10-10 | S-1 | S-1 (registration) | LIFECORE BIOMEDICAL, INC. \DE\ | 0001628280-24-042662 ↗ |
| 2024-10-15 | EFFECT | EFFECT (declared effective) | LIFECORE BIOMEDICAL, INC. \DE\ | 9999999995-24-003178 ↗ |
| 2024-10-22 | EFFECT | EFFECT (declared effective) | LIFECORE BIOMEDICAL, INC. \DE\ | 9999999995-24-003238 ↗ |
| 2025-09-30 | EFFECT | EFFECT (declared effective) | LIFECORE BIOMEDICAL, INC. \DE\ | 9999999995-25-003247 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-10 | S-1 | registration statement | $7.97 | 866,569 | $6,906,554 | Nasdaq LFCR | 1 | primary document; price sentence, shares headline, proceeds computed, underwriting table 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| TOMPKINS NICHOLAS | Director; Director,Officer | Senior Vice President | 41 | 2006–2016 | |
| STEELE GARY T | Director; Director,Officer | CEO and President | 67 | 2006–2018 | |
| TAFT DAVID D | Officer | Chief Operating Officer | 29 | 2006–2010 | |
| BITLER STEVEN P | Officer | Vice President, Technology | 26 | 2006–2018 | |
| BRISTOW DUKE K | Director | 18 | 2006–2013 | ||
| FRANK FRED | Director | Director | 84 | 2006–2020 | |
| HALPRIN STEPHEN E | Director | 25 | 2006–2014 | ||
| JONES KENNETH E | Director | 12 | 2006–2009 | ||
| SCHNEIDER RICHARD S | Director | 13 | 2006–2011 | ||
| SKINNER GREGORY S | Officer | Chief Financial Officer; VP Finance and Admin & CFO | 46 | 2006–2020 | |
| Tobin Robert | Director | 33 | 2006–2019 | ||
| Midyett Ronald Lane | Officer | Chief Operations Officer; Executive Vice President | 27 | 2008–2018 | |
| GOLDBY STEVEN D | Director | 26 | 2008–2019 | ||
| Hemmeter Molly | Officer | Chief Commercial Officer; Chief Executive Officer; Chief Operating Officer; VP Business Development | 24 | 2009–2019 | |
| Hollis Richard Dean | Director | 13 | 2009–2015 | ||
| ALLINGHAM DENNIS J | Officer | Executive Vice President; President & CEO, Lifecore | 4 | 2010–2013 | |
| Hajduk Damian A. | Officer | Chief Scientific Officer | 4 | 2010–2013 | |
| LANDES JOSHUA | TenPercentOwner | 10 | 2012–2024 | ||
| OBUS NELSON | Director; TenPercentOwner | 44 | 2012–2026 | ||
| WYNNEFIELD CAPITAL INC | TenPercentOwner | 10 | 2012–2024 | ||
| Wynnefield Capital, Inc. Profit Sharing Plan | TenPercentOwner | 10 | 2012–2024 | ||
| WYNNEFIELD CAPITAL MANAGEMENT LLC | TenPercentOwner | 10 | 2012–2024 | ||
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP | TenPercentOwner | 10 | 2012–2024 | ||
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | TenPercentOwner | 10 | 2012–2024 | ||
| WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND LTD | TenPercentOwner | 10 | 2012–2024 | ||
| PANKOPF TONIA L | Director | 24 | 2012–2022 | ||
| Sohn Catherine A. | Director | 23 | 2012–2022 | ||
| HIEBERT LARRY D | Officer | Executive Vice President | 8 | 2013–2017 | |
| Bolles Albert D. | Director; Officer | CEO; Chief Executive Officer | 18 | 2014–2022 | |
| Carosella Deborah D | Director | 14 | 2017–2022 | ||
| Hall James G | Director,Officer; Officer | Chief Executive Officer; Executive Vice President; Vice President | 18 | 2017–2023 | |
| Javid Parker K | Officer | Vice President | 5 | 2018–2019 | |
| Powell Andrew Kenneth William | Director | 12 | 2018–2022 | ||
| Burgess Timothy P | Officer | Senior VP of Supply Chain | 6 | 2019–2021 | |
| HOUDE LOVAS KATRINA | Director | 15 | 2019–2026 | ||
| Barbarosh Craig A. | Director | 14 | 2019–2024 | person page Fuzzy | |
| MACALUSO CHARLES | Director | 5 | 2019–2020 | ||
| McLaughlin Brian F | Officer | Chief Financial Officer; Vice President | 6 | 2019–2020 | |
| Kimball Dawn | Officer | Chief People Officer | 4 | 2019–2021 | |
| EDWARDS JEFFREY L | Director | 11 | 2020–2024 | ||
| Schechter Joshua | Director | 14 | 2020–2026 | ||
| Walsh Patrick D | Director | 5 | 2020–2021 | ||
| Morberg John D | Officer | Chief Financial Officer | 17 | 2021–2024 | |
| Diradoorian Raymond H | Director | 9 | 2022–2024 | ||
| Calloway Nathaniel | Director | 7 | 2023–2024 | ||
| Kiper Christopher S | Director; Director,TenPercentOwner | 8 | 2023–2026 | ||
| Legion Partners Asset Management, LLC | Director; Director,TenPercentOwner | 8 | 2023–2026 | ||
| Legion Partners Holdings, LLC | Director; Director,TenPercentOwner | 8 | 2023–2026 | ||
| Legion Partners, LLC | Director; Director,TenPercentOwner | 8 | 2023–2026 | ||
| Legion Partners, L.P. I | Director; Director,TenPercentOwner | 8 | 2023–2026 | ||
| Legion Partners, L.P. II | Director; Director,TenPercentOwner | 8 | 2023–2026 | ||
| White Raymond T. | Director; Director,TenPercentOwner | 8 | 2023–2026 | ||
| Josephs Paul | Director,Officer | Chief Executive Officer | 7 | 2024–2026 | |
| Antunes Humberto Calheiros | Director | 5 | 2024–2026 | ||
| Aryeh Jason | Director | 4 | 2024–2026 | ||
| Korenberg Matthew E | Director | 4 | 2024–2026 | ||
| Johnson Paul Harold | Director | 4 | 2024–2026 | ||
| Lake Ryan David | Officer | Chief Financial Officer | 6 | 2024–2025 | |
| Salus Thomas D. | Officer | Chief Legal & Administration | 5 | 2025–2026 | |
| 22NW Fund GP, LLC | TenPercentOwner | 4 | 2025 | ||
| 22NW Fund, LP | TenPercentOwner | 4 | 2025 | ||
| 22NW GP, Inc. | TenPercentOwner | 4 | 2025 | ||
| 22NW, LP | TenPercentOwner | 4 | 2025 | ||
| English Aron R. | TenPercentOwner | 4 | 2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2018-12-06 | LANDEC CORP \CA\ | Other | $19,360,924 | $19,360,924 | 13 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | LIFECORE BIOMEDICAL INC. | MN | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | LANDEC CORP \CA\ | CA | Form D private offerings | CIK (EXACT) |
| SEC filer | LIFECORE BIOMEDICAL, INC. \DE\ | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | LIFECORE BIOMEDICAL INC. | EIN (EXACT) | ||
| Person page | Craig A Barbarosh | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, MN first:
- Panbela Therapeutics, Inc. MN
- DiaMedica Therapeutics Inc. MN
- Enterologics, Inc. MN
- Vireo Growth Inc. MN
- Squarex Pharmaceutical Corp MN
- Life Science Holdings, Inc. MN
- CIMA LABS INC MN
- MorphoSys AG 2M
- Affimed N.V. 2M
- InflaRx N.V. 2M
In other datasets, the same topic (Health) in MN:
- Nonprofit: ABBOTT NORTHWESTERN HOSPITAL FOUNDATION (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health